Bingyu Xie
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A bispecific-aptamer TSHR-CD80-1 treats thyroid eye disease by inhibiting CD8+ T cell-fibroblast interactions.
Journal: Cell communication and signaling : CCS
Published: February 03, 2026
Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy.
Journal: Investigative ophthalmology & visual science
Published: August 25, 2025
The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease.
Journal: Investigative ophthalmology & visual science
Published: July 14, 2025
GPX1-driven selenium nanoplatform reprograms MAMs-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease.
Journal: Theranostics
Published: May 15, 2025
Biglycan knockdown improves Graves' orbitopathy (GO)-like features via inhibiting NF-kB and ERK signaling.
Journal: Journal of endocrinological investigation
Published: April 25, 2025
Triamcinolone Acetonide (TCA)-Loaded Biodegradable Microspheres Improve Therapeutic Outcomes in Thyroid-Associated Ophthalmopathy (TAO) by Reducing Fibrosis and Adipogenesis.
Journal: Journal of biomedical materials research. Part A
Published: March 05, 2025
Bispecific aptamers target thyrotropin receptor (TSHR) and insulin growth factor-1 receptor (IGF-1R) for the improvement of orbital fibroblasts activation in the treatment of thyroid-associated ophthalmopathy.
Journal: International journal of biological macromolecules
Published: February 11, 2025
Orbital decompression improves visual function and macular blood perfusion status in patients with thyroid-related eye disease.
Journal: Frontiers in medicine
Published: June 26, 2024
Elucidating the role of genetically determined metabolites in Diabetic Retinopathy: insights from a mendelian randomization analysis.
Journal: Acta diabetologica
Published: January 08, 2024
Construction of predictive ceRNA network and identification of the patterns of immune cells infiltrated in Graves' ophthalmopathy.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: October 24, 2023
Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study.
Journal: Journal of the Endocrine Society
Published: August 18, 2023
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
Journal: Journal of translational medicine
Published: September 28, 2022
Last Updated: 09/26/2026